Biological therapies for inflammatory pouch disorders: insights and outcomes from the RESERVO study of GETECCU

Francisco Mesonero, Yamile Zabana, Agnès Fernández-Clotet, Eduardo Leo-Carnerero, Berta Caballol, Andrea Núñez, María José García, Federico Bertoletti, Guillermo Bastida, Gerard Suris, Begoña Casis, Rocío Ferreiro-Iglesias, Margalida Calafat, Itxaso Jiménez, José Miranda-Bautista, Luis Javier Lamuela, Ingrid Fajardo, Leyanira Torrealba, Rodrigo Nájera, Rosa María Sáiz-Chumillas, Irene González-Partida, Miren Vicuña, Natalia García-Morales, Ana Gutiérrez, Alicia López-García, José Manuel Benítez, Cristina Rubín de Célix, Coral Tejido, Eduard Brunet-Mas, Alejandro Hernandez-Camba, Cristina Suarez Ferrer, Iago Rodríguez-Lago, Marta Piqueras, Andrés Castaño, Laura Ramos, Ana Sobrino, María Carmen Rodríguez-Grau, Alfonso Elosua, Miguel A. Montoro-Huguet, Ruth Baltar, José María Huguet, Benito Hermida, Antonio Caballero-Mateos, Luis Sánchez-Guillén, Abdel Bouhmidi, Ramón Pajares, Iria Baston-Rey, Antonio López-Sanromán, Agustín Albillos, Manuel Barreiro-de Acosta, on behalf of the GETECCU Young Members Group

Therapeutic Advances in Gastroenterology

Published online on February 19, 2026

Abstract

Therapeutic Advances in Gastroenterology, Volume 19, January-December 2026.
Background:Inflammatory pouch disorders can be refractory to conventional therapy. Evidence on biological therapy from large cohorts is scarce.Objective:To explore the use and effectiveness of biological therapy for inflammatory pouch disorders.Design:A ...